KHI Monthly Mixer: Highlighting a KHI Project: Advancing Proteinuria as an Endpoint in FSGS

This interactive mixer will highlight the Kidney Health Initiative's (KHI) project on proteinuria as a potential endpoint for Focal Segmental Glomerulosclerosis (FSGS). Attendees will explore the evolution of endpoints used in FSGS clinical trials, key insights from the project's recent publication, and the implications for regulatory and clinical decision-making. The discussion will address the importance of proteinuria reduction, challenges in its validation as a surrogate endpoint, and the next steps in advancing drug development for FSGS.